Low-dose naltrexone ( DrugBank: Naltrexone )


1 disease
IDDisease name (Link within this page)Number of trials
226Interstitial cystitis with Hunners ulcer2

226. Interstitial cystitis with Hunners ulcer


Clinical trials : 143 Drugs : 171 - (DrugBank : 56) / Drug target genes : 64 - Drug target pathways : 145
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT04313972
(ClinicalTrials.gov)
September 7, 202116/3/2020IC PaIN Trial: Interstitial Cystitis Pain Improvement With NaltrexoneIC PaIN Trial: Interstitial Cystitis Pain Improvement With Naltrexone, the Effect of Low Dose Naltrexone on Symptoms and Pain of Patients With Interstitial Cystitis/Painful Bladder Syndrome a Randomized Placebo-controlled Prospective TrialInterstitial Cystitis;Painful Bladder Syndrome;Bladder Pain Syndrome;Low Dose Naltrexone;Low-dose Naltrexone;NaltrexoneDrug: low-dose naltrexone;Drug: Placebo oral tabletNorthShore University HealthSystemNULLRecruiting18 Years110 YearsFemale44Phase 4United States
2NCT04450316
(ClinicalTrials.gov)
October 8, 202024/6/2020Low-dose Naltrexone for Bladder Pain SyndromeLow-dose Naltrexone for Bladder Pain Syndrome: A Randomized Placebo-controlled Prospective Pilot TrialBladder Pain Syndrome;Interstitial CystitisDrug: Naltrexone;Drug: PlaceboStanford UniversityNULLRecruiting18 YearsN/AAll40Phase 2United States